Neuralink Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
492
- Latest Deal Type
-
2ndary - Private
- Investors
-
92
Neuralink General Information
Description
Developer of an implantable brain-machine interface designed to help people with paralysis. The company's interface treats and diagnoses neurological conditions in humans and, conceivably, augments human cognitive powers, enabling doctors to treat serious brain diseases in the short term.
Contact Information
Website
www.neuralink.comCorporate Office
- 7400 Paseo Padre Parkway
- Fremont, CA 94555
- United States
Corporate Office
- 7400 Paseo Padre Parkway
- Fremont, CA 94555
- United States
Neuralink Timeline
Neuralink Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Secondary Transaction - Private | 26-Feb-2026 | Completed | Clinical Trials - General | |||
| 7. Later Stage VC (Series E) | 15-Aug-2025 | Completed | Clinical Trials - General | |||
| 6. Later Stage VC (Series D) | 19-Apr-2024 | Completed | Clinical Trials - General | |||
| 5. Later Stage VC (Series C) | 30-Jul-2021 | Completed | Clinical Trials - General | |||
| 4. Early Stage VC (Series B) | 28-Jun-2019 | Completed | Clinical Trials - General | |||
| 3. Accelerator/Incubator | 09-Apr-2019 | Completed | Clinical Trials - General | |||
| 2. Early Stage VC (Series A) | 24-Aug-2017 | $107M | $107M | Completed | Clinical Trials - General | |
| 1. Accelerator/Incubator | Completed | Clinical Trials - General |
Neuralink Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series E | ||||||||
| Series D | ||||||||
| Series C | ||||||||
| Series B1 | ||||||||
| Series B | 13,391,700 | $0.001000 | $0.19 | $3.82 | $3.82 | 1x | $3.82 | 7.01% |
| Series A | 107,000,000 | $0.001000 | $0.05 | $1 | $1 | 1x | $1 | 55.99% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Neuralink Comparisons
Industry
Financing
Details
Neuralink Competitors (11)
One of Neuralink’s 11 competitors is Precision Neuroscience, a Venture Capital-Backed company based in New York, NY.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Precision Neuroscience | Venture Capital-Backed | New York, NY | ||||
| AliveCor | Venture Capital-Backed | Mountain View, CA | ||||
| BrainGate | Venture Capital-Backed | Providence, RI | ||||
| Kernel (Monitoring Equipment) | Venture Capital-Backed | Los Angeles, CA | ||||
| Augmedics | Venture Capital-Backed | Arlington Heights, IL |
Neuralink Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
News about Neuralink
Dive into recent articles by PitchBook offering invaluable insights and context.
Neuralink Patents
Neuralink Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20250357905-A1 | Integrated circuit amplifier with gate tunneling resistor | Pending | 16-May-2024 | ||
| US-20240386571-A1 | Vascular segmentation and avoidance using imaging | Pending | 18-May-2023 | ||
| US-12547711-B2 | Out-of-band pairing for wireless neural implant | Active | 11-Jan-2023 | ||
| US-20240232340-A1 | Out-of-band pairing for wireless neural implant | Active | 11-Jan-2023 | ||
| US-12550780-B2 | Die reconstitution and high-density interconnects for embedded chips | Active | 18-Oct-2022 | H10W74/43 |
Neuralink Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Neuralink Investors (92)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Gatsby Management | Venture Capital | Minority | ||
| 1789 Capital Management | Venture Capital | Minority | ||
| 1802 Ventures | Venture Capital | Minority | ||
| Alexander Capital Ventures | Venture Capital | Minority | ||
| Align Ventures | Venture Capital | Minority |
Neuralink FAQs
-
When was Neuralink founded?
Neuralink was founded in 2016.
-
Where is Neuralink headquartered?
Neuralink is headquartered in Fremont, CA.
-
What is the size of Neuralink?
Neuralink has 492 total employees.
-
What industry is Neuralink in?
Neuralink’s primary industry is Therapeutic Devices.
-
Is Neuralink a private or public company?
Neuralink is a Private company.
-
What is Neuralink’s current revenue?
The current revenue for Neuralink is .
-
How much funding has Neuralink raised over time?
Neuralink has raised $1.34B.
-
Who are Neuralink’s investors?
Gatsby Management, 1789 Capital Management, 1802 Ventures, Alexander Capital Ventures, and Align Ventures are 5 of 92 investors who have invested in Neuralink.
-
Who are Neuralink’s competitors?
Precision Neuroscience, AliveCor, BrainGate, Kernel (Monitoring Equipment), and Augmedics are some of the 11 competitors of Neuralink.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
